Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Avidity Biosciences, Inc. Director's Dealing 2020

Jul 27, 2020

30894_dirs_2020-07-27_0df393b6-896f-4419-9d7f-d6feaddd2727.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2020-07-27

Reporting Person: Kim Jae B. (Chief Medical Officer)